Anbio Biotechnology Net Fee Amt
Anbio Biotechnology (NNNN) had Net Fee Amt of $0 as of 2026-07-03, per its F-3ASR filed 2026-07-09.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-09
- 2026-07-03: Net Fee Amt $0.00.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-03 | $0.00 F-3ASR · filed 2026-07-09 |